Geneva Capital Management’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.8M | Buy |
199,092
+9,780
| +5% | +$921K | 0.31% | 79 |
|
|
2025
Q1 | $22.5M | Buy |
189,312
+299
| +0.2% | +$35.5K | 0.42% | 70 |
|
|
2024
Q4 | $24.9M | Sell |
189,013
-2,963
| -2% | -$391K | 0.43% | 65 |
|
|
2024
Q3 | $24.9M | Buy |
191,976
+3,732
| +2% | +$485K | 0.42% | 76 |
|
|
2024
Q2 | $16.3M | Sell |
188,244
-6,086
| -3% | -$528K | 0.3% | 84 |
|
|
2024
Q1 | $21.3M | Buy |
194,330
+4,801
| +3% | +$527K | 0.38% | 80 |
|
|
2023
Q4 | $19.9M | Sell |
189,529
-5,683
| -3% | -$595K | 0.38% | 80 |
|
|
2023
Q3 | $20.5M | Buy |
195,212
+3,542
| +2% | +$372K | 0.43% | 76 |
|
|
2023
Q2 | $24.6M | Sell |
191,670
-3,471
| -2% | -$446K | 0.49% | 70 |
|
|
2023
Q1 | $34.1M | Buy |
195,141
+3,325
| +2% | +$581K | 0.69% | 52 |
|
|
2022
Q4 | $31.9M | Buy |
191,816
+87,031
| +83% | +$14.5M | 0.72% | 55 |
|
|
2022
Q3 | $14.8M | Buy |
+104,785
| New | +$14.8M | 0.34% | 90 |
|